Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw

被引:54
作者
Cella, Luigi [1 ,2 ]
Oppici, Aldo [1 ,2 ]
Arbasi, Mariacristina [3 ]
Moretto, Mauro [3 ]
Piepoli, Massimo [4 ]
Vallisa, Daniele [5 ]
Zangrandi, Adriano [6 ]
Di Nunzio, Camilla [5 ]
Cavanna, Luigi [5 ]
机构
[1] Hosp Piacenza, Dept Oral Surg, I-29100 Pisa, Italy
[2] Hosp Piacenza, Dept Maxillofacial Surg, I-29100 Pisa, Italy
[3] Hosp Piacenza, Dept Immunohematol, I-29100 Pisa, Italy
[4] Hosp Piacenza, Dept Cardiol, I-29100 Pisa, Italy
[5] Hosp Piacenza, Dept Hematol & Oncol, I-29100 Pisa, Italy
[6] Hosp Piacenza, Dept Pathol, I-29100 Pisa, Italy
关键词
Osteonecrosis of the Jaw; bisphoshonate; stem cell transplantation; organ repair; PROGENITOR CELLS; STROMAL CELLS; CANCER; PREVENTION; GUIDELINES; DIAGNOSIS; NECROSIS;
D O I
10.1186/1746-160X-7-16
中图分类号
R78 [口腔科学];
学科分类号
100302 [口腔临床医学];
摘要
Purpose: Bisphosphonate - related osteonecrosis of the JAW (BRONJ) is a well known side effect of bisphosphonate therapies in oncologic and non oncologic patients. Since to date no definitive consensus has been reached on the treatment of BRONJ, novel strategies for the prevention, risk reduction and treatment need to be developed. We report a 75 year old woman with stage 3 BRONJ secondary to alendronate and pamidronate treatment of osteoporosis. The patient was unresponsive to recommended treatment of the disease, and her BRONJ was worsening. Since bone marrow stem cells are know as being multipotent and exhibit the potential for differentiation into different cells/tissue lineages, including cartilage, bone and other tissue, we performed autologous bone marrow stem cell transplantation into the BRONJ lesion of the patient. Methods: Under local anesthesia a volume of 75 ml of bone marrow were harvested from the posterior superior iliac crest by aspiration into heparinized siringes. The cell suspension was concentrated, using Ficoll - Hypaque (R) centrifugation procedures, in a final volume of 6 ml. Before the injection of stem cells into the osteonecrosis, the patient underwent surgical toilet, local anesthesia was done and spongostan was applied as a carrier of stem cells suspension in the bone cavity, then 4 ml of stem cells suspension and 1 ml of patient's activated platelet-rich plasma were injected in the lesion of BRONJ. Results: A week later the residual spongostan was removed and two weeks later resolution of symptoms was obtained. Then the lesion improved with progressive superficialization of the mucosal layer and CT scan, performed 15 months later, shows improvement also of bone via concentric ossification: so complete healing of BRONJ (stage 0) was obtained in our patient, and 30 months later the patient is well and without signs of BRONJ. Conclusion: To our knowledge this is the first case of BRONJ successfully treated with autologous stem cells transplantation with a complete response.
引用
收藏
页数:6
相关论文
共 41 条
[1]
American Dental Association Council on Scientific Affairs, 2006, J Am Dent Assoc, V137, P1144
[2]
Antal Salamon, 2009, Orvosi Hetilap, V150, P1259, DOI 10.1556/OH.2009.28666
[3]
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells [J].
Asahara, T ;
Takahashi, T ;
Masuda, H ;
Kalka, C ;
Chen, DH ;
Iwaguro, H ;
Inai, Y ;
Silver, M ;
Isner, JM .
EMBO JOURNAL, 1999, 18 (14) :3964-3972
[4]
Jaw osteonecrosis associated with bisphosphonates:: Multiple exposed areas and its relationship to teeth extractions.: Study of 20 cases [J].
Bagan, JV ;
Jimenez, Y ;
Murillo, J ;
Hernandez, S ;
Poveda, R ;
Sanchis, JM ;
Díaz, JM ;
Scully, C .
ORAL ONCOLOGY, 2006, 42 (03) :327-329
[5]
Mobilization and homing of bone marrow stromal cells in myocardial infarction [J].
Bittira, B ;
Shum-Tim, D ;
Al-Khaldi, A ;
Chiu, RCJ .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 24 (03) :393-398
[6]
Boissier S, 1997, CANCER RES, V57, P3890
[7]
Osteonecrosis of the jaw.: A newly emerging site-specific osseous pathology in patients with cancer treated with bisphosphonates.: Report of five cases and review of the literature [J].
Cavanna, Luigi ;
Berte, Raffaella ;
Arcari, Annalisa ;
Mordenti, Patrizia ;
Pagani, Raffaella ;
Vallisa, Daniele .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2007, 18 (05) :417-422
[8]
DEVELOPMENT OF AN OSTEOGENIC BONE-MARROW PREPARATION [J].
CONNOLLY, J ;
GUSE, R ;
LIPPIELLO, L ;
DEHNE, R .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1989, 71A (05) :684-691
[9]
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw [J].
Edwards, Beatrice J. ;
Gounder, Mrinal ;
Mckoy, June M. ;
Boyd, Ian ;
Farrugia, Mathew ;
Migliorati, Cesar ;
Marx, Robert ;
Ruggiero, Salvatore ;
Dimopoulos, Meletios ;
Raisch, Dennis W. ;
Singhal, Seema ;
Carson, Ken ;
Obadina, Eniola ;
Trifilio, Steve ;
West, Dennis ;
Mehta, Jayesh ;
Bennett, Charles L. .
LANCET ONCOLOGY, 2008, 9 (12) :1166-1172
[10]
Osteomylelitis and necrosis of the jaw in patients treated with bisphosphonates: a comparative study focused on multiple myeloma [J].
Elad, S. ;
Yarom, N. ;
Hamed, W. ;
Ayalon, S. ;
Yahalom, R. ;
Regev, E. .
CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (06) :393-398